文献速递烧伤

重度烧伤中氧雄龙与睾酮转氨酶升高发生率初步分析

A Preliminary Analysis of the Incidence of Transaminitis Observed in Oxandrolone Versus Testosterone Therapy in Major Burn Injury.
PubMed 文献 · J Burn Care Res · 2026-01-01

After major burn injury, patients experience a hypermetabolic response leading to catabolic effects. Anabolic steroids have been investigated to combat these effects.…

要点

  • 氧雄龙组与睾酮组中位住院时间分别为28天和36天,死亡率分别为21%和6%。

核心结论

  • 初步数据显示氧雄龙较睾酮有转氨酶升高发生率更高的趋势,但无统计学显著性。

研究设计与样本

  • 单中心、回顾性队列研究,纳入至少20%体表面积烧伤的成年患者,氧雄龙组52例、睾酮组18例。

主要发现

  • 中位住院时间氧雄龙组28天 vs 睾酮组36天,死亡率氧雄龙组21% vs 睾酮组6%。

临床怎么用

  • 重度烧伤患者使用氧雄龙或睾酮时,需关注转氨酶升高及提前停药的可能性。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

After major burn injury, patients experience a hypermetabolic response leading to catabolic effects. Anabolic steroids have been investigated to combat these effects. Oxandrolone, the primary anabolic steroid used to combat burn hypermetabolism, was removed from the US market in June 2023, and our institution implemented testosterone as an alternative. A known side effect of anabolic steroid use is transaminitis. This study aims to compare the incidence of transaminitis between oxandrolone and testosterone in patients with major burn injury. A single-center, retrospective cohort study was conducted to evaluate adult patients with at least 20% BSA burn injury who received either testosterone or oxandrolone. The primary outcome evaluated was incidence of transaminitis. Secondary outcomes included the need for dose reduction or discontinuation of the steroid, length of stay (LOS), and mortality. Preliminary data were analyzed for significance. Seventy patients received either oxandrolone (n = 52) or testosterone (n = 18). Demographics were similar. The incidence of transaminitis was not statistically significant between oxandrolone and testosterone, 38% vs 28% (P = .596). The rate of dose decrease between the 2 groups was not significant, 17% vs 0% (P = .071). There was a statistically significant difference in early discontinuation of the drug between the groups, 33% oxandrolone vs 0% testosterone (P = .014). The median LOS was 28 and 36 days, respectively, with a mortality rate of 21% and 6% in each group. Preliminary data from this study demonstrate a trend to higher incidence of oxandrolone transaminitis in comparison to testosterone, without statistical significance.

来源:J Burn Care Res,查看原文。版权归原作者所有。

引用

  1. DeWitt A, Hoppe A, Ivanko A, et al. A Preliminary Analysis of the Incidence of Transaminitis Observed in Oxandrolone Versus Testosterone Therapy in Major Burn Injury. J Burn Care Res. 2026. PMID: 40568970. doi:10.1093/jbcr/iraf118

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。